Mr De Silva is an experienced life sciences investment professional with knowledge of the biotech, pharmaceutical and medical technology sectors. Mr De Silva is currently the Founder and Managing Partner of KP Rx, an ANZ focused healthcare VC firm. KP Rx is seeded and supported by Karst Peak Capital where Mr De Silva was the Head of Healthcare Research until December 2022. Prior to moving into life science investment, he worked at Eli Lilly in various roles focused on the commercialization of new and existing pharmaceuticals. Mr De Silva is a non-executive director of Melbourne and Philadelphia based CurveBeam Al and Sydney based Inventia Life Sciences, Melbourne based Navi Medical Technologies and Auckland based Kitea Health.
